Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

08 mars 2026 00h25 HE | Source: The Rosen Law Firm PA

ROSEN, A LEADING AND RANKED FIRM, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO

NEW YORK, March 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADS”) of Mereo BioPharma Group plc (NASDAQ:...
08 mars 2026 00h15 HE | Source: The Rosen Law Firm PA

ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Masonite International Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOOR

NEW YORK, March 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds sellers of common stock of Masonite International Corporation (NYSE: DOOR) between June...
08 mars 2026 00h02 HE | Source: The Rosen Law Firm PA

ROSEN, LEADING TRIAL ATTORNEYS, Encourages NuScale Power Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SMR

NEW YORK, March 08, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of NuScale Power Corporation (NYSE: SMR) between May...
07 mars 2026 23h54 HE | Source: The Rosen Law Firm PA

ROSEN, A TOP RANKED LAW FIRM, Encourages Navan, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NAVN

NEW YORK, March 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Navan, Inc....
07 mars 2026 23h12 HE | Source: The Rosen Law Firm PA

ROSEN, LEADING TRIAL ATTORNEYS, Encourages Lakeland Industries, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LAKE

NEW YORK, March 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Lakeland Industries,...
07 mars 2026 23h02 HE | Source: The Rosen Law Firm PA

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ENPH

NEW YORK, March 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Enphase Energy, Inc. (NASDAQ: ENPH) between April 22, 2025...
07 mars 2026 22h03 HE | Source: Edelson Lechtzin LLP

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Persons Affected by the Banner Capital Bank Data Breach

Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims against Banner Capital Bank.
07 mars 2026 21h58 HE | Source: Edelson Lechtzin LLP

DATA BREACH ALERT: Edelson Lechtzin LLP is Investigating Claims on Behalf of Persons Affected by the TriZetto Provider Solutions (TPS) Data Breach

Edelson Lechtzin LLP is investigating data privacy claims against TriZetto Provider Solutions.
07 mars 2026 17h18 HE | Source: The Rosen Law Firm PA

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Boston Scientific Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - BSX

NEW YORK, March 07, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Boston Scientific...
07 mars 2026 15h15 HE | Source: Kessler Topaz Meltzer & Check LLP

Ultragenyx Pharmaceutical Inc. (RARE) Investors: April 6, 2026, Filing Deadline in Securities Fraud Class Action - Contact Kessler Topaz Meltzer & Check, LLP

Did you buy RARE common stock between August 3, 2023, and December 26, 2025? Affected Ultragenyx Pharmaceutical Inc. Investor Summary Who: Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE)What:...

Page suivante